Disease control rate at 8 weeks predicts subsequent survival in platinum-treated extensive stage small cell lung cancer: Results from the Southwest Oncology Group (SWOG) database

BACKGROUND: Overall response rate is frequently used as an endpoint in phase II trials of platinum-treated extensive stage small-cell lung cancer (ES-SCLC). We hypothesized that disease control rate (DCR) would be a superior surrogate for subsequent survival outcomes. METHODS: Updated patient-level...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Lung Cancer
Glavni autori: Lara, Primo N., Moon, James, Redman, Mary W., Semrad, Thomas J., Kelly, Karen, Allen, Jeffrey, Gitlitz, Barbara, Mack, Philip C., Gandara, David R.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4789142/
https://ncbi.nlm.nih.gov/pubmed/26498504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2015.09.003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items